67 related articles for article (PubMed ID: 23789452)
1. [Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].
Astaf'ev AV; Styrt EA; Sinopal'nikov AI
Klin Med (Mosk); 2013; 91(3):44-50. PubMed ID: 23789452
[TBL] [Abstract][Full Text] [Related]
2. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
3. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Lode H; Eller J; Linnhoff A; Ioanas M;
Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.
Qian J; Ye F; Zhang J; Yang YM; Tu HM; Jiang Q; Shang L; Pan XL; Shi RH; Zhang GX
Helicobacter; 2012 Dec; 17(6):478-85. PubMed ID: 23067317
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Petitpretz P; Choné C; Trémolières F;
Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
[TBL] [Abstract][Full Text] [Related]
9. An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
Jareoncharsri P; Bunnag C; Fooanant S; Tunsuriyawong P; Voraprayoon S; Srifuengfung S; Dhiraputra C
Rhinology; 2004 Mar; 42(1):23-9. PubMed ID: 15072030
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Grossman RF; Ambrusz ME; Fisher AC; Khashab MM; Kahn JB
Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
[TBL] [Abstract][Full Text] [Related]
11. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
12. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
[TBL] [Abstract][Full Text] [Related]
13. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
Lode H; Magyar P; Muir JF; Loos U; Kleutgens K;
Clin Microbiol Infect; 2004 Jun; 10(6):512-20. PubMed ID: 15191378
[TBL] [Abstract][Full Text] [Related]
14. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
16. [Treatment effects of co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: clinical evaluation].
Andrijević I; Povazan D; Andrijević L; Povazan A; Milutinov S
Med Pregl; 2011; 64(3-4):178-82. PubMed ID: 21905596
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation].
Faber M; Jahnz-Rózyk K; Targowski T; Mamełka B
Pol Merkur Lekarski; 2003 Jan; 14(79):36-8. PubMed ID: 12712826
[TBL] [Abstract][Full Text] [Related]
18. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
[TBL] [Abstract][Full Text] [Related]
19. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs].
Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV
Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954
[TBL] [Abstract][Full Text] [Related]
20. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
